http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005208069-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d249a4698cb89e3eb811d2f47114b5e4 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-3156 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate | 2005-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06cad394120936e44458b78f88fb2b5c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c3d668e1ff6e5e0fbe7ac33a3e5124d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ac1e49d10cea2a35b9f6135ee6db8cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1609e829cde5ac3009940369f002513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c66387bc5cf6328674c1fcaef9afc5cc |
| publicationDate | 2005-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2005208069-A1 |
| titleOfInvention | Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
| abstract | This invention provides an isolated polypeptide comprising an amino acid sequence of a N-terminal choline binding protein A truncate in which the amino acid sequence is set forth in any of SEQ ID NOS: 1, 3-7, or 9-11, including fragments, mutants, variants, analogs, or derivatives, thereof. Also, this invention provides a isolated polypeptide comprising an amino acid sequence of a N-terminal choline binding protein A truncate, wherein the amino acid is set forth in SEQ ID NO: 24, wherein the polypeptide retains its native tertiary structure and methods of preparation. This invention provides an isolated polypeptide comprising an amino acid sequence of a N-terminal choline binding protein A truncate, wherein the polypeptide has lectin activity and does not bind to choline. This invention provides an isolated immunogenic polypeptide comprising an amino acid sequence of a N— terminal choline binding protein A truncate. This invention provides an isolated nucleic acid encoding a polypeptide comprising an amino acid sequence of a N— terminal choline binding protein A truncate. Lastly, this invention provides pharmaceutical compositions, vaccines, and diagnostic and therapeutic methods of use. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8722055-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7479282-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004120966-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9249199-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010143394-A1 |
| priorityDate | 1998-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 876.